many investigational and small companies are coming into existence with blood glucose monitoring devices. F. Hoffmann-La Roche, Abbott, Dexcom, Medtronic, Ascensia Diabetes Care Holdings AG ...

DUBAI — Bayer Health Care’s Diabetes Care Division is launching Ascensia Contour blood glucose meter, a new self-testing system to help provide comprehensive diabetes control. The new meter is ...

Senseonics (NYSE:SENS) announced preliminary financial results for 2024 as it considers a reverse stock split.

Strategically, Senseonics called off a Special Meeting of Stockholders scheduled to review a reverse stock split. Management ...

implantable continuous glucose monitor (CGM) systems for people with diabetes, in partnership with our global commercial partner, Ascensia Diabetes Care, and St. Louis-based Mercy, a leading ...

implantable continuous glucose monitoring (CGM) systems for people with diabetes, today provided commercial updates related to the Eversense® 365 launch. Launched Eversense 365 in October ...

GERMANTOWN, Md., Jan. 08, 2025 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable ...

For important safety information, see Ascensia Diabetes Care is a global ... We are home to the world-renowned CONTOUR portfolio of blood glucose monitoring systems and the exclusive global ...